Such NGFR-high melanomas have previously described to be refractory to MAPK inhibition and anti–programmed cell death 1 therapy (27), and we hereby show that such melanoma cells develop rapidly growing melanomas with sustained dedifferentiation status in vivo and have scattered MITF+ melanoma cells in the tumor. This evidence concerns the gene MITF and neoplasm.